These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 4295595)
1. On the use and abuse of LSD. Freedman DX Arch Gen Psychiatry; 1968 Mar; 18(3):330-47. PubMed ID: 4295595 [No Abstract] [Full Text] [Related]
2. [Hashish and LSD. Physical and psychic effects. 1]. Remschmidt H Med Klin; 1972 May; 67(20):706-16 contd. PubMed ID: 5042087 [No Abstract] [Full Text] [Related]
3. [Use and abuse of LSD]. Ladee GA Ned Tijdschr Geneeskd; 1968 May; 112(18):879-84. PubMed ID: 5668465 [No Abstract] [Full Text] [Related]
4. Long lasting effects of LSD on normals. McGlothlin W; Cohen S; McGlothlin MS Arch Gen Psychiatry; 1967 Nov; 17(5):521-32. PubMed ID: 6054248 [No Abstract] [Full Text] [Related]
5. Psychedelics - Re-opening the doors of perception. Heal DJ; Henningfield J; Frenguelli BG; Nutt DJ; Smith SL Neuropharmacology; 2018 Nov; 142():1-6. PubMed ID: 30144477 [No Abstract] [Full Text] [Related]
6. A review of lysergic acid diethylamide (LSD) in the treatment of addictions: historical perspectives and future prospects. Liester MB Curr Drug Abuse Rev; 2014; 7(3):146-56. PubMed ID: 25563445 [TBL] [Abstract][Full Text] [Related]
8. THE USE OF LYSERGIC ACID DIETHYLAMIDE (LSD) IN PSYCHOTHERAPY. BAKER EF Can Med Assoc J; 1964 Dec; 91(23):1200-2. PubMed ID: 14226093 [TBL] [Abstract][Full Text] [Related]
9. Some clinical and social aspects of lysergic acid diethylamidel. II. Sarwer-Foner GJ Psychosomatics; 1972; 13(5):309-16. PubMed ID: 4605126 [No Abstract] [Full Text] [Related]
10. LSD subcultures: acidoxy versus orthodoxy. Gioscia V Am J Orthopsychiatry; 1969 Apr; 39(3):428-36. PubMed ID: 5783739 [No Abstract] [Full Text] [Related]
11. Lysergic acid diethylamide (LSD-25) and schizophrenic reactions. A comparative study. Langs RJ; Barr HL J Nerv Ment Dis; 1968 Aug; 147(2):163-72. PubMed ID: 5677324 [No Abstract] [Full Text] [Related]
12. Psychedelic drugs and creativity. Krippner S J Psychoactive Drugs; 1985; 17(4):235-45. PubMed ID: 4087078 [No Abstract] [Full Text] [Related]
13. The "bad trip"--the etiology of the adverse LSD reaction. Ungerleider JT; Fisher DD; Fuller M; Caldwell A Am J Psychiatry; 1968 May; 124(11):1483-90. PubMed ID: 4384739 [No Abstract] [Full Text] [Related]
14. Chemical agents for behavior change: "creative, psychotic and ecstatic states"--some implications for drug education. McWhinnie HJ Br J Addict Alcohol Other Drugs; 1970 Aug; 65(2):123-37. PubMed ID: 5274149 [No Abstract] [Full Text] [Related]
16. Lysergic acid diethylamide (LSD 25). XXXXI. The use of LSD as an adjunct to psychotherapy: fact and fiction. Abramson HA J Asthma Res; 1973 Jun; 10(4):227-35. PubMed ID: 4744918 [No Abstract] [Full Text] [Related]
17. THE HYPNOTIC TRANCE, THE PSYCHEDELIC EXPERIENCE, AND THE CREATIVE ACT. KRIPPNER S Am J Clin Hypn; 1964 Oct; 7():140-7. PubMed ID: 14215079 [No Abstract] [Full Text] [Related]
18. LSD research: the impact of lay publicity. Dahlberg CC; Mechaneck R; Feldstein S Am J Psychiatry; 1968 Nov; 125(5):685-9. PubMed ID: 5683460 [No Abstract] [Full Text] [Related]
19. Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects. Strassman RJ J Nerv Ment Dis; 1995 Mar; 183(3):127-38. PubMed ID: 7891058 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy. Naranjo C; Shulgin AT; Sargent T Med Pharmacol Exp Int J Exp Med; 1967; 17(4):359-64. PubMed ID: 5631047 [No Abstract] [Full Text] [Related] [Next] [New Search]